Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PTEN

Phosphatase and tensin homolog (PTEN) is a protein that, in humans, is encoded by the PTEN gene. Mutations of this gene are a step in the development of many cancers. Genes corresponding to PTEN (orthologs) have been identified in most mammals for which complete genome data are available. PTEN acts as a tumor suppressor gene through the action of its phosphatase protein product. This phosphatase is involved in the regulation of the cell cycle, preventing cells from growing and dividing too rapidly. It is a target of many anticancer drugs.

  • Cucurbitacin B
    T34046199-67-3
    Cucurbitacin B (Cuc B) has profound in vitro and in vivo antiproliferative effects against human pancreatic Y cells. It inhibited AKT signaling activation through up-regulation of PTEN. Cucurbitacin B is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung Y cells.
    • $44
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Oroxin B
    T3780114482-86-9
    Oroxin B (Hypocretin-2) has antioxidant activity.
    • $110
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • VO-Ohpic trihydrate
    T7012476310-60-8
    VO-Ohpic trihydrate (VO-Ohpic) is a potent inhibitor of PTEN (phosphatase and tensin homolog) with IC50 of 35 nM.
    • $52
    In Stock
    Size
    QTY
  • BpV(HOpic)
    T7953722494-26-0
    BpV(HOpic) (bpV (HOpic)) is a potent inhibitor of PTEN (IC50 of 14 nM).
    • $59
    In Stock
    Size
    QTY
  • MTK458
    T724202499962-58-0
    MTK458 (EP-0035985) is an orally active and brain-permeable PINK1 activator that promotes pathological clearance of alpha-synuclein and reduces pUb in a PFF inoculation model.MTK458 induces pathological alpha-synuclein clearance by stimulating dimerization and stabilization of the PINK1/TOM complex.MTK458 may be used in Parkinson's disease research.
    • $32
    In Stock
    Size
    QTY
  • SF1670
    T6667345630-40-2
    SF1670 (PTPase CD45 Inhibitor) is a specific PTEN inhibitor with IC50 of 2 μM.
    • $37
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Ginkgolic acid C17:1
    T6S2116111047-30-4
    1. Ginkgolic acid C17:1 can significantly inhibit enterohemorrhagic Escherichia coli O157:H7(EHEC) biofilm formation on the surfaces of polystyrene and glass, and on nylon membranes.
    • $92
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Afzelin
    TN1362482-39-3
    Afzelin (Kaempferol-3-O-rhamnoside) exhibits several cellular activities such as DNA-protective, antibacterial, antioxidant, anti-inflammatory, and UV-absorbing properties, potentially protecting human skin from UVB-induced damage through a combination of UV-absorbing and cellular actions. Afzelin mitigates mitochondrial damage, promotes mitochondrial biogenesis, and reduces levels of mitophagy-related proteins, parkin and PTEN-induced putative kinase 1.
    • $41
    In Stock
    Size
    QTY
  • Valinomycin
    TP10722001-95-8
    Valinomycin (NSC-122023) is a cyclic depsipeptide antibiotic and a potassium-specific ionophore.Valinomycin induces PINK1 activation and promotes Parkin phosphorylation at Ser65.
    • $29
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
  • bpV(phen)
    T1059442494-73-5
    bpV(phen) is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor (IC50s: 343 nM, 920 nM, and 38 nM for PTP-β, PTP-1B, and PTEN).
    • $1,520
    6-8 weeks
    Size
    QTY